Sushil Patel
Chief Executive Officer at Replimune Group; Director at Revolution Medicines. Based in Woburn, Massachusetts.
- Rank
- 6072nd of 14,644
- Companies held
- 2
- Largest holding
- REPL, 78.6% of total
- Latest SEC filing
- Nov 16, 2026
What the $16.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Replimune Group REPL Common Stock | Directly | 659,125 | $19.23 | $12.7M | 78.6% | Form 4, Nov 16, 2026 |
| Revolution Medicines RVMD Common Stock | Directly | 21,656 | $159.43 | $3.5M | 21.4% | Form 4, Jun 29, 2026 |
Share counts are the amounts Sushil Patel reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Sold | REPL | 49,026 | $21.60 | $1.1M | View |
| Aug 10, 2026 | Sold | REPL | 39,341 | $12.97 | $510K | View |
| Jun 29, 2026 | Sold | RVMD | 300 | $183.17 | $55K | View |
| Jun 29, 2026 | Sold | RVMD | 900 | $184.59 | $166K | View |
| Jun 29, 2026 | Sold | RVMD | 1,100 | $185.90 | $204K | View |
| Jun 29, 2026 | Sold | RVMD | 881 | $192.61 | $170K | View |
| Jun 29, 2026 | Sold | RVMD | 300 | $187.83 | $56K | View |
| Jun 29, 2026 | Sold | RVMD | 100 | $188.57 | $19K | View |
| Jun 29, 2026 | Sold | RVMD | 600 | $190.55 | $114K | View |
| Jun 29, 2026 | Sold | RVMD | 541 | $191.87 | $104K | View |
| Jun 29, 2026 | Sold | RVMD | 858 | $186.92 | $160K | View |
| May 18, 2026 | Sold | REPL | 37,324 | $5.08 | $190K | View |
| Dec 2, 2025 | Sold | REPL | 10,000 | $11.13 | $111K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6069 | Patricia Higgins Director, The Travelers Companies. St. Paul, MN | $16.1M |
| 6070 | Williams Ena Koschel Chief Operating Officer, Casey's General Stores. Ankeny, IA | $16.1M |
| 6071 | Chad Gassert SVP - CORP. DEV. & STRATEGY, ANI Pharmaceuticals. Baudette, MN | $16.1M |
| 6072 | Sushil Patel Chief Executive Officer, Replimune Group. Woburn, MA | $16.1M |
| 6073 | Gary E. Hendrickson Director, James Hardie Industries. Medina, MN | $16.1M |
| 6074 | Kenneth L. Custer EVP & President, Card Met Hlth, Eli Lilly and. Indianapolis, IN | $16.1M |
| 6075 | Gerald Creadon EVP, Operations, Jabil. St. Petersburg, FL | $16.1M |
Other Replimune Group insiders
All REPL insiders- Robert Coffin$35.0MDirector. #3332 overall
- Philip Astley-Sparke$26.2MDirector. #4211 overall
- Colin Love$14.9MChief Operating Officer. #6463 overall
- Pamela Esposito$5.1MChief Business Officer. #14086 overall
- Emily Luisa Hill$3.9MChief Financial Officer. #12562 overall
- Jean M. Franchi$2.5MChief Financial Officer. #10931 overall
Questions
How much stock does Sushil Patel own?
Sushil Patel holds $16,127,590 in listed stock based on SEC filings and current prices, mostly Replimune Group (REPL). That ranks 6072nd on the Stock Rich List.
Is this Sushil Patel's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Sushil Patel last buy or sell stock?
The most recent open-market trade on file is a sale of 49,026 REPL shares on Nov 16, 2026 at $21.60.